title: [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
abstract: The search for the ideal antihypertensive drug is ongoing. Carvedilol is a new beta-adrenoceptor antagonist which also causes peripheral vasodilation primarily via alpha 1-adrenergic blockade. Twenty patients with mild to moderate essential hypertension and previous intolerance and side effects to other antihypertensive drugs were studied. After initial baseline assessment, patients received 25 mg carvedilol orally q.d. The treatment lasted 60 days. In our study carvedilol was well tolerated and no important side effect was recorded. Blood pressure decreased significantly to normal values, without orthostatic blood pressure decreases. Heart rate decreased significantly too, but no significant bradycardia was induced. No negative effects on serum lipids and no clinical evidence of increase in peripheral resistance were observed. Ventricular arrhythmia on Holter monitoring were significantly reduced after treatment with carvedilol.
authors.affiliation: Servizio di Cardiologia, UTIC, Ospedale di Rapallo, Genova.
authors.forename: M
authors.initials: M
authors.lastname: Perocchio
authors.forename: G
authors.initials: G
authors.lastname: Gigli
authors.forename: M
authors.initials: M
authors.lastname: Barra
authors.forename: R
authors.initials: R
authors.lastname: Sacchetti
authors.forename: A
authors.initials: A
authors.lastname: Vallebona
authors.forename: G A
authors.initials: GA
authors.lastname: Rosolen
authors.forename: S
authors.initials: S
authors.lastname: Orlandi
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002227:Carbazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000077261:Carvedilol; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol
vernacular_title: Trattamento beta-alpha-bloccante bilanciato con carvedilolo nell'ipertensione arteriosa lieve-moderata.